Search

Fenosup Lidose

Fenosup Lidose

fenofibrate

Manufacturer:

Hyphens

Distributor:

Pan-Malayan
Concise Prescribing Info
Contents
Fenofibrate
Indications/Uses
Hypercholesterolaemia & hypertriglyceridaemia alone or combined (types IIa, IIb, III, IV, V dyslipidaemias); secondary hyperlipoproteinaemias.
Click to view Fenosup Lidose detailed prescribing information
Overdosage
View Fenosup Lidose overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take during meals. Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity. Renal & hepatic insufficiency (eg, biliary cirrhosis). Gallbadder disease. Pregnancy & lactation. Childn.
Click to view Fenosup Lidose detailed prescribing information
Special Precautions
Every 3 mth monitoring of transaminase levels (discontinue if AST & ALT levels is >3 times the upper limit of the normal range). Patient treated concomitantly w/ HMG-CoA reductase inhibitors should be monitored for muscle toxicity.
Click to view Fenosup Lidose detailed prescribing information
Adverse Reactions
Digestive, gastric or intestinal disorders (eg, abdominal pain, nausea, vomiting, diarrhoea & flatulence); skin rashes, pruritus, urticaria, photosensitivity reactions (eg, cutaneous photosensitivity) w/ erythema, vesiculation or nodulation.
Click to view Fenosup Lidose detailed prescribing information
Drug Interactions
May increase risk of bleeding w/ oral anticoagulants. Cyclosporin, HMG-CoA reductase inhibitors & other fibrates.
Click to view Fenosup Lidose detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Fenosup Lidose detailed prescribing information
Storage
View Fenosup Lidose storage conditions for details to ensure optimal shelf-life.
Description
View Fenosup Lidose description for details of the chemical structure and excipients (inactive components).
Action
View Fenosup Lidose mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Fenosup Lidose cap 160 mg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in